Kaiba was just a newborn when he turned blue because his little lungs weren’t getting the oxygen they needed. Garrett spent the first year of his life in hospital beds tethered to a ventilator, being fed through his veins because his body was too sick to absorb food. Baby Ian’s heart stopped before he was even six months old.

With higher deductibles and more price-conscious healthcare consumers, as a result of the Affordable Care Act, improving the performance, comfort and speed of MRI scans can be an important strategy for imaging centers that must compete by offering the best patient care and experience.

Researchers studying cancer and other invasive diseases rely on high-resolution imaging to see tumors and other activity deep within the body’s tissues. Using a new high-speed, high-resolution imaging method, Lihong Wang, Ph.D., and his team at Washington University in St. Louis were able to see blood flow, blood oxygenation, oxygen metabolism and other functions inside a living mouse brain at faster rates than ever before.

Varian Medical Systems last week unveiled a radiotherapy platform designed to offer clinics an affordable option for implementing advanced image-guided radiotherapy. Varian's VitalBeam system is a cost-effective technology package for offering high-quality, high-throughput radiation therapy, and for expanding clinical capabilities over time.

Brainlab expanded on its “Elements” strategy for treatment of brain and spine tumors with the introduction of automated stereotactic radiosurgery (SRS) planning tools. Announced at the third European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona, Spain, the SRS tools enable on-the-fly generation of consistent treatment plans for volumetric arc therapy (VMAT) delivery.

Volpara Solutions announced the release of VolparaDensity version 3.1 at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Florida, April 25-28.

Ion Beam Applications S.A. (IBA) and Pravida Bau GmBH announced an agreement to supply integrated single-room proton therapy solutions to customers in Europe.

brachytherapy, ESTRO, radiotherapy, five-year recurrence, ASCENDE-RT

Results from a randomized controlled trial comparing permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer showed brachytherapy patients were twice as likely to be cancer-free five years later.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now